3/17
04:42 pm
antx
AN2 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business and Scientific Highlights [Yahoo! Finance]
Medium
Report
AN2 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business and Scientific Highlights [Yahoo! Finance]
3/17
04:00 pm
antx
AN2 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business and Scientific Highlights
Medium
Report
AN2 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business and Scientific Highlights
3/9
08:12 am
antx
AN2 Therapeutics raises $40M privately [Seeking Alpha]
High
Report
AN2 Therapeutics raises $40M privately [Seeking Alpha]
3/9
07:03 am
antx
AN2 Therapeutics Announces $40 Million Private Placement Financing [Yahoo! Finance]
High
Report
AN2 Therapeutics Announces $40 Million Private Placement Financing [Yahoo! Finance]
3/9
07:00 am
antx
AN2 Therapeutics Announces $40 Million Private Placement Financing
High
Report
AN2 Therapeutics Announces $40 Million Private Placement Financing
3/3
04:11 pm
antx
AN2 Therapeutics Announces Plans to Advance Oral Epetraborole into Phase 2 Study for Polycythemia Vera (PV) [Yahoo! Finance]
High
Report
AN2 Therapeutics Announces Plans to Advance Oral Epetraborole into Phase 2 Study for Polycythemia Vera (PV) [Yahoo! Finance]
3/3
04:00 pm
antx
AN2 Therapeutics Announces Plans to Advance Oral Epetraborole into Phase 2 Study for Polycythemia Vera (PV)
High
Report
AN2 Therapeutics Announces Plans to Advance Oral Epetraborole into Phase 2 Study for Polycythemia Vera (PV)
2/17
07:21 am
antx
AN2 Therapeutics to Participate in Fireside Chat at Leerink Global Healthcare Conference [Yahoo! Finance]
Low
Report
AN2 Therapeutics to Participate in Fireside Chat at Leerink Global Healthcare Conference [Yahoo! Finance]
2/17
07:00 am
antx
AN2 Therapeutics to Participate in Fireside Chat at Leerink Global Healthcare Conference
Low
Report
AN2 Therapeutics to Participate in Fireside Chat at Leerink Global Healthcare Conference
1/12
07:00 am
antx
AN2 Therapeutics Announces FDA Clearance to Proceed with 90-Patient Investigator-Initiated Trial (IIT) of Epetraborole in Patients with M. abscessus Lung Disease
High
Report
AN2 Therapeutics Announces FDA Clearance to Proceed with 90-Patient Investigator-Initiated Trial (IIT) of Epetraborole in Patients with M. abscessus Lung Disease